Frontiers in Physiology (Dec 2021)
Corrigendum: Chrysophanol Relieves Cisplatin-Induced Nephrotoxicity via Concomitant Inhibition of Oxidative Stress, Apoptosis, and Inflammation
- Siqing Ma,
- Siqing Ma,
- Siqing Ma,
- Siqing Ma,
- Heng Xu,
- Weihua Huang,
- Weihua Huang,
- Weihua Huang,
- Weihua Huang,
- Yongchao Gao,
- Yongchao Gao,
- Yongchao Gao,
- Yongchao Gao,
- Honghao Zhou,
- Honghao Zhou,
- Honghao Zhou,
- Honghao Zhou,
- Xiong Li,
- Wei Zhang,
- Wei Zhang,
- Wei Zhang,
- Wei Zhang
Affiliations
- Siqing Ma
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Siqing Ma
- Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, China
- Siqing Ma
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Siqing Ma
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Heng Xu
- Department of Laboratory Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
- Weihua Huang
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Weihua Huang
- Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, China
- Weihua Huang
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Weihua Huang
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Yongchao Gao
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Yongchao Gao
- Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, China
- Yongchao Gao
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Yongchao Gao
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Honghao Zhou
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Honghao Zhou
- Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, China
- Honghao Zhou
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Honghao Zhou
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- Xiong Li
- The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong, China
- Wei Zhang
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China
- Wei Zhang
- Hunan Key Laboratory of Pharmacogenetics, Institute of Clinical Pharmacology, Central South University, Changsha, China
- Wei Zhang
- Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China
- Wei Zhang
- National Clinical Research Center for Geriatric Disorders, Changsha, China
- DOI
- https://doi.org/10.3389/fphys.2021.794302
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
